Related Experiment Video
Updated: May 8, 2026

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
Published on: August 10, 2015
Engineered Extracellular Vesicles in Chronic Kidney Diseases: A Comprehensive Review
1Department of Integrated Traditional Chinese and Western Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, People's Republic of China.
Engineered extracellular vesicles (EVs) offer promising targeted drug delivery for chronic kidney diseases (CKD). This review details EV engineering, renal delivery, therapeutic effects, and clinical translation challenges for CKD treatment.
Area of Science:
- Biomedical engineering and regenerative medicine.
- Nanotechnology and drug delivery systems.
- Nephrology and kidney disease research.
Background:
- Chronic kidney diseases (CKD) represent a significant global health burden with limited effective treatments.
- Extracellular vesicles (EVs) are increasingly recognized for their potential as versatile drug delivery vehicles.
- Engineered EVs present a novel therapeutic strategy for targeted drug delivery in complex diseases like CKD.
Purpose of the Study:
- To systematically review extracellular vesicles (EVs) for chronic kidney disease (CKD) management.
- To explore EV classification, biogenesis, composition, engineering techniques, and renal delivery strategies.
- To summarize the therapeutic applications and evaluate the clinical translation of engineered EV therapies for CKD.
Main Methods:
- Systematic review of existing literature on extracellular vesicles (EVs) and chronic kidney disease (CKD).
- Analysis of EV engineering techniques, including cargo loading and targeted renal delivery.
- Evaluation of therapeutic effects such as anti-inflammatory, immunomodulatory, renoprotective, and tissue-regenerating properties.
Main Results:
- Engineered EVs demonstrate significant potential for targeted drug delivery in CKD.
- EVs exhibit diverse therapeutic effects including anti-inflammatory, immunomodulatory, renoprotective, and tissue-regenerating capabilities.
- Key challenges in clinical translation and future research directions for EV-based CKD therapies are identified.
Conclusions:
- Engineered extracellular vesicles (EVs) show considerable promise as a therapeutic modality for chronic kidney diseases (CKD).
- Further research and development are crucial to overcome challenges in the clinical application of EV-based therapies for CKD.
- Future prospects involve refining EV engineering and delivery for enhanced efficacy and broader clinical adoption in nephrology.
More Related Videos
09:00Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
Published on: March 27, 2018
08:50Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics
Published on: August 16, 2024
Related Concept Videos
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management